ArticleMolecular and clinical oncology2015

Evaluation of the efficacy of maintenance therapy for low-to-intermediate-risk acute promyelocytic leukemia in molecular remission: A retrospective single-institution study.

Masahide Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.